Your browser doesn't support javascript.
loading
5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study.
Janowska, Agata; Papa, Giovanni; Romanelli, Marco; Davini, Giulia; Oranges, Teresa; Stocco, Chiara; Arnez, Zoran Marji; Dini, Valentina.
Afiliação
  • Janowska A; Department of Dermatology, University of Pisa, Pisa, Italy.
  • Papa G; Department of, Medical, Surgical and Health Sciences, Plastic and Reconstructive Surgery Unit, University of Trieste, Trieste, Italy.
  • Romanelli M; Department of Dermatology, University of Pisa, Pisa, Italy.
  • Davini G; Department of Dermatology, University of Pisa, Pisa, Italy.
  • Oranges T; Department of Dermatology, University of Pisa, Pisa, Italy.
  • Stocco C; Department of Health Sciences, Anna Meyer Children University Hospital, University of Florence, Florence, Italy.
  • Arnez ZM; Department of, Medical, Surgical and Health Sciences, Plastic and Reconstructive Surgery Unit, University of Trieste, Trieste, Italy.
  • Dini V; Department of, Medical, Surgical and Health Sciences, Plastic and Reconstructive Surgery Unit, University of Trieste, Trieste, Italy.
J Invest Surg ; 35(1): 49-52, 2022 Jan.
Article em En | MEDLINE | ID: mdl-32969736
ABSTRACT

BACKGROUND:

Lidocaine hydrochloride is frequently used for management of painful wounds. This prospective, multicentre study examined the effects of 5% lidocaine cream on wound pain relief. MATERIAL AND

METHODS:

The study included 78 patients with painful wounds treated with 5% Lidocaine cream for two weeks in two Italian Hospitals. Patients' perception of pain was recorded by, using the 5-point Visual Rate Scale and the 11-point Numerical Pain Rating Scale. All medications and adverse events were evaluated in a daily diary. The primary outcome of the study was establishing the wound pain relief based on the results of 5-VRS and pain intensity based on the 11-NPRS testing from baseline to the end of treatment. Clinical aspects and adverse events were also collected.

RESULTS:

Seventy-eight patients had a median age of 67.5 years (range 18-96 years). 62.8% were women. The wounds included traumatic wounds (n = 39), venous ulcers (n = 25), post-surgical wounds (n = 6) pyoderma gangrenosum (n = 6), vasculitis (n = 1) and pressure ulcer (n = 1). The intensity of pain significantly decreased from the baseline level established at the beginning of treatment (mean score 6.7 - 1.90) - to the level at end of treatment (3.0 - 2.23-; p < 0.0001). 9 patients prematurely stopped the treatment for healing (n = 4), wound improvement (n = 2) and adverse events related to the treatment. (n = 3). 13 patients presented a total of 25 adverse events, 4 of them were related to the treatment.

CONCLUSION:

The treatment of painful wounds with 5% Lidocaine Cream for 14 days resulted in reduced pain intensity, and showed high safety and tolerability.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Dor / Ferimentos e Lesões / Lidocaína Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Dor / Ferimentos e Lesões / Lidocaína Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Surg Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália